Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)
22.22 x 113 22.61 x 1
Post-market by (Cboe BZX)
22.45 +0.68 (+3.12%) 04/24/25 [NYSE Arca]
22.22 x 113 22.61 x 1
Post-market 22.47 +0.02 (+0.09%) 16:30 ET
Quote Overview for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
21.71
Day High
22.48
Open 21.90
Previous Close 21.77 21.77
Volume 1,516,106 1,516,106
Avg Vol 3,599,090 3,599,090
Stochastic %K 87.39% 87.39%
Weighted Alpha -9.12 -9.12
5-Day Change +1.65 (+7.93%) +1.65 (+7.93%)
52-Week Range 17.50 - 31.16 17.50 - 31.16
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 943,820,600
  • Shares Outstanding, K 43,350
  • 60-Month Beta 1.50
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.382 on 12/29/21
  • Management Fee 0.75%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 53.21% ( -8.96%)
  • Historical Volatility 63.63%
  • IV Percentile 82%
  • IV Rank 39.19%
  • IV High 86.12% on 04/08/25
  • IV Low 31.99% on 12/24/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 3,138
  • Volume Avg (30-Day) 20,272
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 351,813
  • Open Int (30-Day) 372,759

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.50 +28.25%
on 04/07/25
Period Open: 24.09
24.12 -6.92%
on 03/25/25
-1.64 (-6.81%)
since 03/24/25
3-Month
17.50 +28.25%
on 04/07/25
Period Open: 27.08
31.16 -27.95%
on 02/18/25
-4.63 (-17.10%)
since 01/24/25
52-Week
17.50 +28.25%
on 04/07/25
Period Open: 23.67
31.16 -27.95%
on 02/18/25
-1.22 (-5.15%)
since 04/24/24

Most Recent Stories

More News
Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase.

ARKG : 22.45 (+3.12%)
SFTBY : 25.5600 (+5.32%)
TEM : 53.50 (+7.97%)
ARKK : 49.99 (+4.25%)
Best-Performing ETFs of Last Week

Wall Street was upbeat last week, with the S&P 500 adding 1.5%, the Dow Jones gaining about 0.6% and the Nasdaq surging 2.6%. Last week witnessed the release of hot January inflation data. The Consumer...

ODDS : 26.84 (-0.04%)
ABNY : 12.09 (+3.75%)
ARKG : 22.45 (+3.12%)
MS : 115.60 (+2.93%)
KWEB : 32.07 (+0.19%)
UNG : 15.50 (-1.46%)
Tempus AI Stock Swings Wildly As Earnings Near, Retail’s Cautiously Optimistic After Insider Sales

The company has gained a lot of attention since launching an AI-enabled personal health app last month.

ARKG : 22.45 (+3.12%)
IBB : 124.20 (+1.80%)
VTI : 268.99 (+2.11%)
TEM : 53.50 (+7.97%)
Cathie Wood Just Doubled Down on This AI Stock. Should You?

The stock is one of the renowned investor’s top holdings.

ARKG : 22.45 (+3.12%)
MRK : 79.84 (+1.40%)
TEM : 53.50 (+7.97%)
ARKK : 49.99 (+4.25%)
TAK : 15.11 (-0.46%)
BNTX : 120.54 (+4.97%)
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens

The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects.

ARKG : 22.45 (+3.12%)
IBB : 124.20 (+1.80%)
XBI : 80.89 (+2.26%)
NTLA : 8.18 (+1.11%)
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now

A regulatory filing from Wednesday night disclosed that Tempus AI founder and CEO Eric Lefkofsky sold 946,084 shares of Tempus between Jan. 15-17.

ARKG : 22.45 (+3.12%)
IBBQ : 20.88 (+1.85%)
TEM : 53.50 (+7.97%)
ARKK : 49.99 (+4.25%)
Here Are the 6 Largest Stock Holdings in All of Cathie Wood's ETFs Right Now

Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs. They all have a different tech-related focus, such as robotics,...

ARKX : 18.36 (+3.15%)
ARKF : 35.53 (+3.38%)
ARKW : 100.44 (+3.59%)
ARKG : 22.45 (+3.12%)
ARKQ : 68.60 (+3.80%)
ARKK : 49.99 (+4.25%)
Options Alert: Should Investors Jump on This Cathie Wood-Owned Life Sciences Specialist?

While proteomics firms Quantum-Si has made waves recently, QSI stock might not be the long-term play value investors are seeking.

ARKG : 22.45 (+3.12%)
QSI : 1.2200 (+4.27%)
1 AI Stock Cathie Wood Is Buying Instead of Tesla

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

TSLA : 259.51 (+3.50%)
ARKG : 22.45 (+3.12%)
TEM : 53.50 (+7.97%)
UTHR : 296.42 (+1.01%)
ARKK : 49.99 (+4.25%)
BNTX : 120.54 (+4.97%)
Best-Performing ETF Areas of Last Week

The Dow Jones Industrial Average and the S&P 500 climbed to new record levels on Friday, closing out a strong month for equities. The Dow Jones rose 1.4% last week, while the S&P 500 and the Nasdaq...

ARKX : 18.36 (+3.15%)
TSLA : 259.51 (+3.50%)
ARKG : 22.45 (+3.12%)
GNOM : 8.19 (+1.36%)
ETH : 16.63 (-1.36%)
HDRO : 25.92 (-0.90%)
XRT : 68.46 (+1.65%)
HYDR : 16.80 (+1.45%)
ETHV : 25.86 (-1.37%)
UFO : 21.96 (+3.58%)
Should You Follow Cathie Wood Into This AI Diagnostics Stock?

This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.

ARKG : 22.45 (+3.12%)
TEM : 53.50 (+7.97%)
ARKK : 49.99 (+4.25%)
Almost Every Ark Fund Is Now Underperforming The Overall Market. Here's Why.

The fund company focuses on the right industries, but these industries' stocks require a very particular economic backdrop and market environment.

ROKU : 64.65 (+3.31%)
$NASX : 17,166.04 (+2.74%)
ARKW : 100.44 (+3.59%)
$SPX : 5,484.77 (+2.03%)
ARKQ : 68.60 (+3.80%)
^MKRBTC : 0.016030 (+3.48%)
COIN : 203.87 (+4.66%)
ARKK : 49.99 (+4.25%)
COMP : 7.36 (+1.80%)
^MKRUSDT : 1,499.194 (+3.29%)
ARKF : 35.53 (+3.38%)
TSLA : 259.51 (+3.50%)
1 Cathie Wood Stock With 55% Upside Potential

This Ark Invest biotech stock pick, with 55% potential upside, garnered a vote of confidence from Jefferies last week.

TXG : 8.31 (+3.68%)
ARKG : 22.45 (+3.12%)
AZTA : 27.13 (+5.16%)
ARKK : 49.99 (+4.25%)
Why Ginkgo Bioworks Stock Is Sinking Today

There was double trouble for this beaten-down biotech stock.

ARKG : 22.45 (+3.12%)
DNA : 7.87 (+3.55%)
ARKK : 49.99 (+4.25%)
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought

These companies could generate explosive growth over time.

ARKG : 22.45 (+3.12%)
CRSP : 39.11 (+1.48%)
VRTX : 492.47 (+0.01%)
NTLA : 8.18 (+1.11%)
Here's How Cathie Wood (Almost) Completely Missed the Boat on Artificial Intelligence (AI) -- and the Simplest Way You Can Avoid Making the Same Mistake

The tide has gone out on ARK Invest's ETFs, and it doesn't look pretty.

COMP : 7.36 (+1.80%)
ARKX : 18.36 (+3.15%)
QQQ : 467.35 (+2.81%)
MGK : 308.68 (+3.10%)
ARKF : 35.53 (+3.38%)
TSLA : 259.51 (+3.50%)
ARKW : 100.44 (+3.59%)
ARKG : 22.45 (+3.12%)
ARKQ : 68.60 (+3.80%)
ARKK : 49.99 (+4.25%)
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?

Teladoc's share performance has reflected its earnings struggles...

TSLA : 259.51 (+3.50%)
CRSP : 39.11 (+1.48%)
ARKG : 22.45 (+3.12%)
TDOC : 7.26 (+2.69%)
ARKK : 49.99 (+4.25%)
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk

You don't need to buy her picks, but it's worth understanding them.

ARKG : 22.45 (+3.12%)
DNA : 7.87 (+3.55%)
RXRX : 5.75 (+3.05%)
RHHBY : 39.7500 (+1.56%)
ARKK : 49.99 (+4.25%)
3 Cathie Wood ETFs Just Hit 4-Month Lows. Are They Worth Buying Now?

Growth-orientated funds could face ongoing pressure in a high-interest-rate environment.

ARKX : 18.36 (+3.15%)
ROKU : 64.65 (+3.31%)
TSLA : 259.51 (+3.50%)
ARKG : 22.45 (+3.12%)
COIN : 203.87 (+4.66%)
ARKK : 49.99 (+4.25%)
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?

What's good for Wood and Ark Invest might not be good for other investors.

ARKG : 22.45 (+3.12%)
PFE : 22.78 (+1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Key Turning Points

3rd Resistance Point 23.49
2nd Resistance Point 22.98
1st Resistance Point 22.72
Last Price 22.45
1st Support Level 21.95
2nd Support Level 21.44
3rd Support Level 21.18

See More

52-Week High 31.16
Fibonacci 61.8% 25.94
Fibonacci 50% 24.33
Fibonacci 38.2% 22.72
Last Price 22.45
52-Week Low 17.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective